Vaxart
Why Robinhood?
You can watch Vaxart and buy or sell other stocks, ETFs, and their options commission-free!About VXRT
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection.
VXRT Key Statistics
Stock Snapshot
With a market cap of 92.71M, Vaxart(VXRT) trades at $0.41. The stock has a price-to-earnings ratio of -1.82.
On 2025-11-16, Vaxart(VXRT) stock traded between a low of $0.36 and a high of $0.42. Shares are currently priced at $0.41, which is +12.5% above the low and -3.6% below the high.
Vaxart(VXRT) shares are trading with a volume of 459.29K, against a daily average of 783.49K.
In the last year, Vaxart(VXRT) shares hit a 52-week high of $0.98 and a 52-week low of $0.26.
In the last year, Vaxart(VXRT) shares hit a 52-week high of $0.98 and a 52-week low of $0.26.
VXRT News
Vaxart ( (VXRT) ) has released its Q3 earnings. Here is a breakdown of the information Vaxart presented to its investors. Meet Your ETF AI Analyst Discover ho...
Earnings Call Insights Vaxart extends cash runway into Q2 2027 with Dynavax partnership and targets 2026 data readouts Nov. 13, 2025 10:42 PM ET Vaxart, Inc. (V...
